Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer

This study has been completed.

Study NCT00081315 Information provided by MedImmune LLC

First Received: April 7, 2004 Last Updated: August 20, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	August 2006
Estimated Primary Completion Date:	No date given